Stock screenerAll disclosures →
EDGAR →
BCDA
Conviction 13HealthcareScan · Mon, Aug 10, 2026BCDA$0.9650-1.36%
ResistanceSupportVol 14Insider buy2
Vol MA14 279.5K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price0.9650
Change-1.36%
Gap-3.88%
Rel volume0.59×
Avg volume297.22K
Avg $ vol261.39K
SMA 200.8695
SMA 500.9374
SMA 2001.16
Price vs 50+2.95%
Price vs 200-17.10%
MA stackmixed
50/200 cross—
Supertrenddown · 1.05
RSI (14)56
MACD hist0.02
MACD crossbull · 4d
Stoch %K / %D90 / 91
ADX (14)20
+DI / −DI20 / 16
RSI divergenceBullish
MACD divergenceBullish
ATR %+8.44%
ADR %8.83%
52w high2.27
52w low0.7711
From 52w high-57.49%
Above 52w low+25.15%
New 52w highNo
SqueezeOff
Bollinger width29.64%
%B0.87
Donchian pos90.41%
Donchian high0.9878
Donchian low0.7500
AVWAP (52w high)1.22
vs AVWAP high-21.00%
AVWAP (52w low)0.9030
vs AVWAP low+6.86%
OBV trendFlat
Chaikin MF (20)-0.10
Today vs 20d0.59×
Avg vol (14d)279.5K
Avg vol (20d)297.22K
Avg $ vol (20d)261.39K
Market cap10.98M
RS 3m (vs SPY)-15.94%
RS 6m (vs SPY)-35.22%
RS line new highNo
Trend template1/8
Technical rank36.3
1 week+16.10%
1 month+5.49%
3 months-13.06%
6 months-22.80%
1 year-42.56%
YTD-24.02%
P/E-1.33
P/B-10.30
P/S22.92
P/FCF-1.47
EPS-1.23
Div yield—
ROE771.86%
ROA-480.61%
Debt/Eq—
Current0.41
EV/EBITDA-1.21
Gross margin12.94%
Net margin—
Rev growth-16.84%
EPS growth-3.55%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value10.03M
Revenue130K
Net income-2.26M
Gross profit69K
Free cash flow-7.44M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out11.37M
Employees21
ListedWed, Oct 25, 1995
Free float7.86M
Float %71.8%
Short interest1.34M
Days to cover2.6d
Short volume19.7%
Squeeze score47 / 100
Next earningsWed, Aug 12, 2026 · after (2d)
EPS forecast−$0.19 · 1 est
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction13 / 100
Pattern quality—
Tech rank36.3 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance1.15
Support0.7758
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in BCDA
No recent disclosed trades by Congress in BCDA. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in BCDA · 10 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Altman Peter President and CEO · Common Stock · 2026-07-15 | Buy | 1.5K | $1K | 2026-07-15 | 2026-07-15 |
Altman Peter President and CEO · Common Stock · 2026-07-14 | Buy | 2.8K | $2K | 2026-07-14 | 2026-07-15 |
Altman Peter President and CEO · Common Stock · 2026-07-10 | Buy | 1K | $940 | 2026-07-10 | 2026-07-10 |
Altman Peter President and CEO · Common Stock · 2026-07-09 | Buy | 1K | $900 | 2026-07-09 | 2026-07-10 |
Altman Peter President and CEO · Common Stock · 2026-07-08 | Buy | 5.5K | $5K | 2026-07-08 | 2026-07-10 |
Altman Peter President and CEO · Common Stock · 2026-07-08 | Buy | 5.4K | $5K | 2026-07-08 | 2026-07-08 |
Facteau Bill Director · Stock Option (right to buy) · 2026-07-06 | Grant | 8K | — | 2026-07-06 | 2026-07-07 |
MOYES JAY M Director · Stock Option (right to buy) · 2026-07-06 | Grant | 8K | — | 2026-07-06 | 2026-07-07 |
Slosman Marvin Director · Stock Option (right to buy) · 2026-07-06 | Grant | 8K | — | 2026-07-06 | 2026-07-07 |
Blank Andrew Scott Director · Stock Option (right to buy) · 2026-07-06 | Grant | 8K | — | 2026-07-06 | 2026-07-07 |
SEC filings
EDGAR filings in BCDA · 4 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.